XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 21.06%776M | 21.06%776M | -91.66%468M | -89.53%590M | -1.58%561M | -6.15%641M | -6.15%641M | 1,205.12%5.61B | 816.26%5.64B | -19.83%570M |
-Cash and cash equivalents | 30.68%592M | 30.68%592M | -95.02%266M | -92.22%416M | 4.02%388M | -9.76%453M | -9.76%453M | 1,674.09%5.34B | 1,077.75%5.35B | -23.25%373M |
-Short-term investments | -2.13%184M | -2.13%184M | -25.74%202M | -39.58%174M | -12.18%173M | 3.87%188M | 3.87%188M | 110.85%272M | 78.88%288M | -12.44%197M |
Receivables | 10.01%1.02B | 10.01%1.02B | 58.66%944M | 60.80%960M | 38.89%925M | 37.22%929M | 37.22%929M | -6.74%595M | -8.44%597M | 7.25%666M |
-Accounts receivable | 10.01%1.02B | 10.01%1.02B | 58.66%944M | 60.80%960M | 38.89%925M | 37.22%929M | 37.22%929M | -6.74%595M | -8.44%597M | 7.25%666M |
Restricted cash | -21.93%5.7B | -21.93%5.7B | -0.89%5.91B | -22.17%5.57B | -21.03%5.62B | 3.58%7.3B | 3.58%7.3B | -37.64%5.96B | -17.91%7.16B | 7.74%7.11B |
Other current assets | 26.84%293M | 26.84%293M | 29.89%239M | 0.00%189M | 14.06%219M | 14.93%231M | 14.93%231M | -18.22%184M | -18.88%189M | -21.63%192M |
Total current assets | -14.40%7.79B | -14.40%7.79B | -38.81%7.56B | -46.17%7.31B | -14.27%7.32B | 5.72%9.1B | 5.72%9.1B | 13.82%12.35B | 32.88%13.58B | 4.43%8.54B |
Non current assets | ||||||||||
Net PPE | -1.02%968M | -1.02%968M | 3.51%972M | 1.06%956M | 1.99%975M | 0.20%978M | 0.20%978M | -2.80%939M | -3.07%946M | -2.55%956M |
-Gross PPE | -40.98%968M | -40.98%968M | 3.51%972M | 1.06%956M | 1.99%975M | 6.84%1.64B | 6.84%1.64B | -2.80%939M | -3.07%946M | -2.55%956M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -18.43%-662M | -18.43%-662M | ---- | ---- | ---- |
Goodwill and other intangible assets | -3.22%20.86B | -3.22%20.86B | 103.54%21.24B | 101.28%21.16B | 99.71%21.27B | 101.83%21.56B | 101.83%21.56B | -0.90%10.43B | -2.87%10.51B | -3.98%10.65B |
-Goodwill | -1.10%13.96B | -1.10%13.96B | 77.33%14.17B | 74.36%13.98B | 72.45%13.97B | 74.24%14.11B | 74.24%14.11B | 0.53%7.99B | -1.61%8.02B | -2.82%8.1B |
-Other intangible assets | -7.23%6.91B | -7.23%6.91B | 189.13%7.07B | 187.99%7.17B | 186.48%7.29B | 188.38%7.44B | 188.38%7.44B | -5.30%2.45B | -6.74%2.49B | -7.49%2.55B |
Other non current assets | 17.14%779M | 17.14%779M | 26.68%793M | 26.81%790M | 11.89%706M | 9.38%665M | 9.38%665M | 5.21%626M | 7.23%623M | 9.74%631M |
Total non current assets | -2.54%22.61B | -2.54%22.61B | 91.70%23B | 89.59%22.9B | 87.54%22.95B | 89.16%23.2B | 89.16%23.2B | -0.75%12B | -2.42%12.08B | -3.24%12.24B |
Total assets | -5.88%30.4B | -5.88%30.4B | 25.50%30.56B | 17.75%30.21B | 45.69%30.27B | 54.75%32.29B | 54.75%32.29B | 6.14%24.35B | 13.55%25.66B | -0.23%20.78B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 41.35%588M | 41.35%588M | 19.02%363M | 34.20%514M | 9.09%336M | -2.80%416M | -2.80%416M | 21.51%305M | 9.43%383M | 28.87%308M |
-accounts payable | -18.98%269M | -18.98%269M | 1.05%289M | 51.26%301M | 45.36%266M | 79.46%332M | 79.46%332M | 51.32%286M | 13.71%199M | -1.61%183M |
-Other payable | 279.76%319M | 279.76%319M | 289.47%74M | 15.76%213M | -44.00%70M | -65.43%84M | -65.43%84M | -69.35%19M | 5.14%184M | 135.85%125M |
Current accrued expenses | 7.26%325M | 7.26%325M | 48.82%314M | 36.54%213M | 19.75%188M | 24.69%303M | 24.69%303M | 2.93%211M | -3.11%156M | -6.55%157M |
Current debt and capital lease obligation | 37.11%399M | 37.11%399M | --499M | 291.43%548M | -35.45%224M | -56.17%291M | -56.17%291M | ---- | -86.27%140M | -68.37%347M |
-Current debt | 37.11%399M | 37.11%399M | --499M | 291.43%548M | -35.45%224M | -56.17%291M | -56.17%291M | ---- | -86.27%140M | -68.37%347M |
Current deferred liabilities | 19.70%711M | 19.70%711M | 47.01%663M | 31.90%736M | 30.42%866M | 66.39%594M | 66.39%594M | 8.67%451M | 8.98%558M | 7.27%664M |
Other current liabilities | -20.78%5.88B | -20.78%5.88B | 0.21%6.09B | -20.54%5.78B | -20.05%5.78B | 3.89%7.42B | 3.89%7.42B | -37.08%6.08B | -17.60%7.27B | 7.43%7.23B |
Current liabilities | -12.44%7.9B | -12.44%7.9B | 12.56%7.93B | -8.46%7.79B | -15.06%7.39B | 2.15%9.03B | 2.15%9.03B | -37.82%7.05B | -21.71%8.51B | -1.66%8.7B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -10.50%9.47B | -10.50%9.47B | -3.53%9.76B | -5.49%9.66B | 95.58%10.18B | 103.97%10.58B | 103.97%10.58B | 101.13%10.12B | 97.81%10.22B | -1.40%5.2B |
-Long term debt | -10.65%9.08B | -10.65%9.08B | -3.55%9.36B | -5.55%9.25B | 105.06%9.77B | 114.64%10.16B | 114.64%10.16B | 112.18%9.7B | 108.52%9.79B | -0.79%4.76B |
-Long term capital lease obligation | -6.95%388M | -6.95%388M | -3.16%399M | -4.22%409M | -6.56%413M | -7.74%417M | -7.74%417M | -9.65%412M | -9.15%427M | -7.53%442M |
Non current deferred liabilities | -2.92%1.59B | -2.92%1.59B | 207.66%1.57B | 244.30%1.63B | 257.45%1.66B | 260.09%1.64B | 260.09%1.64B | 8.30%509M | 2.16%474M | 7.42%463M |
Other non current liabilities | 4.55%230M | 4.55%230M | 11.56%222M | 7.28%221M | -1.33%222M | -2.65%220M | -2.65%220M | -10.76%199M | -15.57%206M | -6.64%225M |
Total non current liabilities | -9.23%11.29B | -9.23%11.29B | 6.68%11.55B | 5.62%11.51B | 104.60%12.06B | 112.00%12.44B | 112.00%12.44B | 89.15%10.82B | 85.55%10.9B | -0.97%5.89B |
Total liabilities | -10.58%19.2B | -10.58%19.2B | 9.00%19.48B | -0.56%19.3B | 33.24%19.45B | 45.99%21.47B | 45.99%21.47B | 4.77%17.87B | 15.92%19.41B | -1.39%14.6B |
Shareholders'equity | ||||||||||
Share capital | 0.00%6M | 0.00%6M | 20.00%6M | 20.00%6M | 20.00%6M | 20.00%6M | 20.00%6M | 0.00%5M | 150.00%5M | 150.00%5M |
-common stock | 0.00%6M | 0.00%6M | 20.00%6M | 20.00%6M | 20.00%6M | 20.00%6M | 20.00%6M | 0.00%5M | 150.00%5M | 150.00%5M |
Retained earnings | 7.36%8.4B | 7.36%8.4B | 5.53%8.18B | 5.91%8.02B | 7.03%7.93B | 8.57%7.83B | 8.57%7.83B | 9.78%7.76B | 10.19%7.57B | 11.28%7.41B |
Paid-in capital | 0.62%5.53B | 0.62%5.53B | 292.90%5.48B | 305.58%5.53B | 321.19%5.53B | 280.35%5.5B | 280.35%5.5B | -0.99%1.39B | -1.59%1.36B | -13.11%1.31B |
Less: Treasury stock | 10.22%647M | 10.22%647M | 9.91%643M | 9.95%641M | 10.09%611M | 13.98%587M | 13.98%587M | 14.71%585M | 14.54%583M | 13.50%555M |
Gains losses not affecting retained earnings | -9.10%-2.1B | -9.10%-2.1B | 7.14%-1.95B | 5.10%-2.01B | -1.89%-2.04B | 3.37%-1.92B | 3.37%-1.92B | -0.48%-2.1B | -11.23%-2.12B | -20.12%-2.01B |
Total stockholders'equity | 3.47%11.19B | 3.47%11.19B | 71.21%11.07B | 74.79%10.9B | 75.27%10.81B | 75.84%10.82B | 75.84%10.82B | 10.08%6.47B | 6.73%6.24B | 2.56%6.17B |
Noncontrolling interests | -18.18%9M | -18.18%9M | -25.00%9M | -16.67%10M | -16.67%10M | -15.38%11M | -15.38%11M | 33.33%12M | 33.33%12M | 33.33%12M |
Total equity | 3.45%11.2B | 3.45%11.2B | 71.03%11.08B | 74.61%10.91B | 75.09%10.82B | 75.65%10.83B | 75.65%10.83B | 10.11%6.48B | 6.77%6.25B | 2.61%6.18B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |